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• Research conduct in Australia and worldwide is mostly 
unaudited.
• The purpose of good research governance is to ensure 
integrity in research through accountability, transparency and 
responsibility.
• Institutional responsibility for research governance has been 
adopted by Monash University’s Department of Epidemiology 
and Preventive Medicine, providing clear lines of accountability 
for researchers as well as support and guidance.
• A research audit tool has been developed, identifying areas 
where practice could be improved especially among less 
experienced researchers; the most common adverse findings 
concerned research protocols and procedure manuals.
• The need for participant confidentiality, privacy and data 
security was found to be understood, and adhered to widely by 
all researchers.
• An evaluation of the effect of audit on researchers found that 
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the process was well accepted.
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wi
diT  scientific community is dependent upon public good-ll and trust, and recent publications,1-4 including thesclosure of the scientific fraud of the South Korean
stem cell researcher Hwang, can only erode the public’s confi-
dence.3
While episodes of identifiable research misconduct or fraud
are rare, breaches in research integrity are more common.1,5,6
an approved
lish key find-
primary out-
amined and,
alia,1,8-10 this
om a human
research ethics committee (HREC), there is no guarantee that
ethical research conduct naturally follows. HRECs are poorly
equipped to exert governance beyond their primary role of the
ethical review of research proposals. They may also lack the
transparency required for good governance.11,12 It is our belief
that it is the structures and processes used to govern the conduct
of research that determine how effectively participants are
protected. Better governance with improved audit may detect
breaches and help prevent research misconduct.
The purpose of research governance is to ensure research
integrity through accountability, transparency and responsibil-
ity.13,14 Good governance also seeks to ensure that research is
carried out with the highest scientific and ethical standards,
appropriate use of finances, and robust monitoring, review and
evaluation processes.13
Research governance frameworks
Frameworks for research governance in the United Kingdom,
the United States and Canada are well established.15-18 The UK
Department of Health introduced the Research governance
framework for health and social care in 2001, and revised it in
2005.17 The US Department of Health and Human Services has
an Office for Human Research Protections (http://www.hhs.gov/
ohrp/), which has a Code of Federal Regulations (Common
Rule) that is legally binding.15 In Canada, research is guided by
the Tri-Council policy statement Ethical conduct for research
involving humans 1998 (with amendments in 2000, 2002 and
2005).18,19
In Australia, there has been a call for greater emphasis on an
institutional model of research governance,11 in the absence of a
national research governance framework. Much of the literature
discusses the cornerstones of governance (transparency,
accountability and responsibility) and their adoption into vari-
ous governance frameworks.12-14 However, there is little in the
literature describing the operational tools for these frameworks,
nor do the frameworks include active audit of research conduct.
Indeed, the US, followed by the UK, have increasingly adopted a
more regulated legislative approach to research conduct.15,17
We describe here the framework for research governance of
the Department of Epidemiology and Preventive Medicine
(DEPM) at Monash University, its operational methods and
tools, and an evaluation of those tools. The operational features
of good governance have been described as including appropri-
ate oversight, sound policies and guidelines, effective implemen-
tation of those policies and guidelines, and continuous
evaluation and feedback.16 While these features are reflected in
the DEPM’s research governance framework, we placed greater
emphasis on audit of research conduct rather than the somewhat
vague notion of “appropriate oversight”.
The DEPM research governance framework
The Head of Department at the DEPM used a risk management
approach to ensuring research is carried out to the highest
scientific and ethical standards. A research governance framework
was established, based on seven guiding principles of good
governance adapted from the OECD (Organisation for Economic
Co-operation and Development) Principles of corporate
governance20 (Box 1).
We implemented a model of institutional responsibility, moving
away from self-regulation and reliance on the HREC approval
process to determine research conduct.1 We also aimed to create a
culture of conscience and responsibility, measuring performance
(what we actually do) rather than compliance (what we are sup-
posed to do).2 Our organisational structure for research governance,
reflecting clear lines of accountability, is given in Box 2.1/12 • 4/18 December 2006 623
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Development of a research audit tool
Two operational methods have been employed. The first was the
development of a research audit tool that can be applied, in part or
full, to any research study or data registry. The tool assesses
compliance with the standards required by the regulatory authori-
ties,8-10 compliance with privacy legislation, and performance
against a higher standard of conduct reflected in the DEPM’s A
guide to good research practice.22 The tool relies heavily on the
International Conference on Harmonisation/Guideline for Good
Clinical Practice (ICH/GCP)9 that provides the only existing
standard for quality improvement in research conduct.
The audit tool initially employed a tick-box mechanism. How-
ever, after auditing six projects, it was redesigned to give a more
accurate delineation of findings, problems and required actions. It
now allows for quicker audit, is easier and simpler to read and,
importantly, enables the auditor to commend researchers for good
research conduct, reinforcing the required standard. We also
attempted to highlight any gaps or deficiencies in departmental
support, particularly for students, and to assess researchers’ under-
standing and practice of data security and privacy. In these
activities, we differed from the usual “monitoring” that occurs
during a pharmaceutical industry-sponsored study.
While our audit tool was initially designed to evaluate specific
components of research conduct, it will evolve to incorporate other
components of good governance, such as financial responsibility,
insurance, intellectual property protection, and complaints handling.
The areas audited were the study protocol, the participant
information and consent form, the HREC approval, other relevant
study documentation, data management and data confidentiality
procedures, and overall study management. We promoted the
actual audit process as educative for the research staff and as a
“work in progress”. A study is not “signed off” until all actions
required are completed, and staff are provided with whatever
assistance or guidance they require.
Studies audited to date have included randomised controlled
trials, observational studies, prospective epidemiological studies,
registries, industry-sponsored trials and PhD projects.
A total of 18 studies were randomly selected for audit by the
Committee during the period 2002–2005. Eighteen other studies
were not audited for a variety of reasons. These included studies
1 Guiding principles and the research governance framework of the Department of Epidemiology and Preventive 
Medicine (DEPM) 
1. Clearly defined accountability and responsibility
• The DEPM (specifically the Head of Department) is ultimately 
accountable for the conduct of research in the Department
• Management arrangements, including reporting lines, have been 
established to support the accountability of the Head of 
Department
• The Monash University Standing Committee on Ethics in Research 
Involving Humans is part of these arrangements and responsible 
for ensuring research proposals are ethically sound
• Research investigators are held accountable for their actions
2. Participation
• A Good Clinical Research Practice Committee governs all 
research associated with the DEPM
• The Committee comprises six staff members who may be 
experienced clinician researchers, research managers, PhD 
supervisors, or senior lecturers. Most have two or more of these 
roles in the Department
• The Committee meets fortnightly and also reports to the Head 
of Department
• The Committee appointed a Research Governance Coordinator 
in 2002 whose central role is research audit, review and evaluation. 
This was an external appointment on a part-time basis. She is an 
experienced researcher who serves on Monash University’s 
Standing Committee on Ethics in Research Involving Humans
3. Transparency
• This is maintained through the DEPM’s reporting arrangements:
¾ The DEPM’s Annual report21
¾ The Good Clinical Research Practice Committee provides 
3-monthly reports to the Head of Department, and 3-monthly 
newsletters to all DEPM staff on matters of research governance
¾ Any conflict of interest of Committee members is declared
4. Technical and managerial competence in research conduct
• Only suitably qualified staff are employed
• Handbooks and training are provided for staff
• All staff sign privacy statements ensuring the confidentiality of 
research participants and meet with the Research Governance 
Coordinator
• Short courses in research process are provided for staff and the 
wider research community. Courses are compulsory for all PhD 
candidates
5. Organisational capacity
• The Research Governance Coordinator’s role is to audit, report on 
and improve the standard of clinical and public health research 
undertaken by researchers within the DEPM
• The Coordinator’s role provides a resource for the DEPM, 
informing research conduct and policy development
• The Coordinator meets with every new staff member as part of the 
induction process and outlines her role
6. Compliance
• Publication of A guide to good research practice22 establishes 
standard procedures for conducting DEPM research, and staff 
are expected to meet the standards it outlines
• Guidelines are reviewed and revised constantly
• Compliance with the AS/NZS Risk Management Standards23 is 
part of this process. An overall risk management strategy is 
included in the DEPM’s A guide to good research practice22
• Risk analysis will be applied to research projects in 2006
7. Audit, review and evaluation
• This is a core operational component of the DEPM framework and 
the central role of the Research Governance Coordinator
• All researchers at DEPM are audited; this is well publicised among 
staff
• An audit template has been developed
• In 2005, PhD candidates were targeted, as individual scientists 
have been described as the most at risk in the literature2
• There is continuous evaluation of the effect of the audit process 
on staff ◆624 MJA • Volume 185 Number 11/12 • 4/18 December 2006
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that it was too early in the life of the study for audit to occur and
the project was re-visited later.
Effect of the audit process
The second operational method or tool involved evaluation of the
effect of the audit process on researchers. The Good Clinical
Research Practice Committee considered carefully the role of the
Research Governance Coordinator as the auditor and potential
conflicts associated with audit, and sought to assess the effect of
the audit process on research staff.
During 2002–2004, 13 studies involving a total of 24 staff were
audited.
Approval from Monash University’s Standing Committee on
Ethics in Research Involving Humans was obtained to distribute an
anonymous, voluntary questionnaire to researchers associated
with the 13 studies. The questionnaire sought to determine:
• how important or relevant audit was to researchers;
• whether they learnt from the process;
• whether they considered the audit to be thorough; and, for
those staff who were not principal investigators,
• whether they felt they had supervisor support during the audit
process.
The self-administered questionnaire, which consisted of seven
questions for all staff and two additional questions for supervised
research staff, was returned by internal mail or by a self-addressed
envelope. The Likert scale24 was employed to measure responses
to a range of statements. Questionnaires were distributed in three
batches: November 2003, and January and March 2004.
Findings of research audits
The most common adverse findings of the audits concerned
research protocols and procedure manuals. While the minimum
standards according to ICH/GCP were generally met, most were
missing one or more requirements; for example, dates signatures,
version numbers, flow charts, timelines, and descriptions of staff
roles. Protocols, protocol amendments and approvals were some-
times not located in hard copy in the study document file or with
the correct (approved) version number and date. Where deficien-
cies were identified, the auditor worked with the research staff to
meet the expected standards.
Differing interpretations of signing a consent form were also a
common finding, with multiple version numbers and dates caus-
ing the most confusion. Just over half the audited studies met the
DEPM standard. HREC approval was problematic if approval time
was short (2 years) for projects funded for 3 or more years. Both
the approving HREC and study personnel often missed the
requirements for annual reports.
The need for research participant confidentiality, privacy and
data security was well understood and adhered to widely by all
researchers and research staff. However, the translation of this
understanding into practice varied among different groups. The
signing of confidentiality statements was monitored for compli-
ance and, while compliance was high and staff understood the
implications of the need for confidentiality in their work, many
could not remember signing the document.
Evaluation of the effect of audit on research staff
Twenty-four staff were surveyed and 17 (63%) completed ques-
tionnaires were returned. Only five of 11 principal investigators
surveyed responded. The poor response from principal investiga-
tors reflected that five of the 11 had left the DEPM and were
unaware of the DEPM’s research governance activities, and poss-
ibly considered their response irrelevant as they were not directly
involved in the audit process. However, five of six principal
investigators located within the DEPM did respond. Of the other
research staff (postdoctoral staff, nurses, research assistants) 12 of
13 responded. Overall:
• 14/17 agreed or strongly agreed that audit is an important part
of the research process;
• 13/17 agreed or strongly agreed that the process of audit was
helpful to their understanding of good clinical research practice;
• 12/17 agreed or strongly agreed that audit was helpful to the
general conduct of the study;
• 11/17 disagreed or strongly disagreed that they felt uncomfort-
able when audited;
• 15/17 agreed or strongly agreed that the audit was thorough;
and
• 16/17 agreed or strongly agreed that the issues raised in the
report of the audited research study were appropriate.
• 10/12 other research staff agreed or strongly agreed that they
had the support of the principal investigators during the audit
process.
Although there was a difference in response rates between
principal investigators and other research staff, responses were
similar across both groups.
Discussion
Although largely untested and based on consensus,25 the ICH/GCP
is the most familiar standard for research practice worldwide. It
was written for the pharmaceutical industry, but is referred to in
the National Health and Medical Research Council’s National
statement on ethical conduct in research involving humans,10 and the
Therapeutic Goods Association bases its guidelines for therapeutic
research on the ICH/GCP.8 Our literature search found only one
example of the ICH/GCP being used systematically to audit
research conduct.26 However, while it is viewed as the minimum
standard, it remains the only guideline for auditing research
2 Organisational structure for research governance at 
Monash University Department of Epidemiology and 
Preventive Medicine
Vice-Chancellor Monash University
Standing Committee on Ethics
in Research Involving Humans
Head of Department
Department of Epidemiology and Preventive Medicine
Principal investigators Good Clinical Research Practice Committee
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ICH/GCP standard, with any deficiencies generally relating to the
higher standard reflected in our guidelines.22 In addition to this,
many of the components of ICH/GCP are not well suited to public
health research and we modified our audit tool accordingly.
Our evaluation of the effect of audit on research staff indicated
that the audit component of risk management planning was well
accepted, non-threatening and that most staff were comfortable
with the process. Further, we were satisfied that research staff felt
that issues raised during audit were appropriate and that principal
investigators strongly supported the audit process involving their
staff.
Overall, we view audit not only as an essential tool of our
research governance framework, but also as an important part of
the research process itself. We found strong support for this, with
audit assisting staff in the required conduct of their research.
The DEPM accepts the model of institutional responsibility for
research governance in an environment in which there are calls for
greater research governance, with some published frameworks
available, but little, if any, measurement of implementation. Audit
is a necessary adjunct to research activity and an important
operational tool of the DEPM research governance framework.
Audit aims to be educative and supportive, rather than policing or
raising issues of conflict for researchers. It is well accepted by staff
and is seen as a necessary part of the research process. The other
operational tools of our framework, the DEPM’s A guide to good
research practice and ongoing education in research conduct appear
to be well accepted, while the final tool, risk analysis of research
projects, is yet to be implemented. Our framework for good
research governance, including its operational tools, is evolving.
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